Warnock D W, Turner A, Burke J
Department of Microbiology, Bristol Royal Infirmary, UK.
J Antimicrob Chemother. 1988 Jan;21(1):93-100. doi: 10.1093/jac/21.1.93.
A reversed-phase high-performance liquid chromatographic (HPLC) method, with internal standard quantification, is described for the analysis of itraconazole in human serum. No interference was encountered from over 60 drugs tested. The standard curve was linear from 10 to 10,000 micrograms/l. The detection limit of the method was 10 micrograms/l, with coefficients of variation from 2.2 to 7.8% over a range of itraconazole concentrations from 20 to 1600 micrograms/l. An agar diffusion method is also described with a lowest reproducible limit of 100 micrograms/l. This method had coefficients of variation from 11.0 to 17.1% over a range of itraconazole concentrations from 100 to 1600 micrograms/l. Comparison of the methods showed that HPLC gave much lower values of itraconazole concentrations in patient serum samples than did the microbiological method.
本文描述了一种采用内标定量的反相高效液相色谱(HPLC)法,用于分析人血清中的伊曲康唑。在所测试的60多种药物中未遇到干扰。标准曲线在10至10,000微克/升范围内呈线性。该方法的检测限为10微克/升,在伊曲康唑浓度为20至1600微克/升的范围内,变异系数为2.2%至7.8%。还描述了一种琼脂扩散法,其最低可重复限度为100微克/升。该方法在伊曲康唑浓度为100至1600微克/升的范围内,变异系数为11.0%至17.1%。方法比较表明,HPLC法测得的患者血清样本中伊曲康唑浓度值比微生物学法低得多。